Search results
3 Cheap Biotech Stocks to Buy Now: May 2024
InvestorPlace· 1 day agoThe biotech industry is notably risky, but can produce stocks that see massive gains within a day. Well, many of these companies depend on FDA approval...
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
Motley Fool via Yahoo Finance· 4 hours agoThat said, this is a high-risk biotech growth stock, meaning investors ought to carefully weigh...
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 7 hours agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -9.80%) stock has...
Warren Buffett Stocks: What's Inside Berkshire Hathaway's Portfolio?
Investor's Business Daily· 2 hours agoLong Term Buffett is known as a buy-and-hold investor, hanging on to stocks for years and even...
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
InvestorPlace· 4 days agoThe biotech sector holds some of the most promising and popular stocks on the market. With the...
3 Must-Have Penny Stocks to Boost Your 2024 Portfolio
InvestorPlace· 1 day agoPenny stocks can be super volatile, but the potential of a modest investment ballooning into a...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 1 hour agoBut some of the predictions farther out are truly tremendous -- such as...a jump from around $55...
Insider Selling: IO Biotech, Inc. (NASDAQ:IOBT) Major Shareholder Sells 658,809 Shares of Stock
ETF DAILY NEWS· 9 hours agoIO Biotech, Inc. (NASDAQ:IOBT – Get Free Report) major shareholder Holdings A/S Novo sold 658,809 shares of the firm’s stock in a transaction that occurred ...
Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout
Investor's Business Daily· 5 days agoAnalysts forecast 2024 EPS of $3.65, representing an increase of 32% year-over-year. On...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 1 day agostock tops more than half of all stocks. Mutual funds hold a good chunk of the biotech stock. As of...